World's First Nasdaq listed Nature-Derived Psilocybin Biopharma arrives on Wall Street. Thank you Nasdaq for welcoming Psyence Biomedical Ltd (NASDAQ:PBM) #FollowThePsyence
Psyence Biomedical Ltd
Research Services
Psyence Biomed is the World's First NASDAQ-listed Nature-Derived Psilocybin Biopharma
About us
Psyence Biomed Ltd., is a pharmaceutical life science biotechnology company traded on the NASDAQ (NASDAQ:PBM), with a focus on botanical psychedelics. Psyence Biomed is the first Nasdaq-listed nature-derived psilocybin biopharma in the world. The name “Psyence” combines the words “psychedelics” and “science” to affirm our commitment to an evidence-based approach to innovative biopharma. Patient-centered, our physician-led company is led by R+D leader CEO Dr. Neil Maresky, MD, who while working at the intersection of medicine, commerce, and science has brought some 50 medicines to market at AstraZeneca, Wyeth, Bayer, and elsewhere. Psyence Biomed is working to develop an FDA-approved pharmaceutical botanical psilocybin for the treatment of oncology patients diagnosed with Adjustment Disorder in a palliative care context to treat psychosocial distress. Our Phase IIb trials have received ethics approval and begin enrolling patients in this quarter.
- Website
-
https://psyencebiomed.com/
External link for Psyence Biomedical Ltd
- Industry
- Research Services
- Company size
- 11-50 employees
- Headquarters
- Toronto
- Type
- Public Company
- Founded
- 2023
- Specialties
- Psilocybin and Palliative Care Research
Locations
-
Primary
Get directions
Toronto , CA
Employees at Psyence Biomedical Ltd
Updates
-
Welcome Professor Dan Stein MD https://lnkd.in/erP8FcjC
-
Psychedelic Invest - Insights and Analyses on Psychedelics has shared the news that Professor Albert Garcia-Romeu, PhD of Johns Hopkins Center for Psychedelic and Consciousness Research has joined Psyence Biomedical Ltd as chair of its Scientific Advisory Board. https://lnkd.in/e7sYpFZv
-
Thank you BioSpace for the warm welcome to Professor Albert Garcia-Romeu, PhD of Johns Hopkins Center for Psychedelic and Consciousness Research as he joins Psyence Biomedical Ltd as chair of its Scientific Advisory Board! https://lnkd.in/ecKTpjha
-
Throwback Thursday to this time last year when Psyence Biomedical Ltd arrived on the Nasdaq. This year: we welcome Dr. Albert Garcia-Romeu, PhD, of the Johns Hopkins Center for Psychedelic and Consciousness Research as he joins Psyence Biomedical Ltd as chair of its Scientific Advisory Board.
Working to bring FDA-approved nature-derived (non-synthetic) #psilocybin for an oncology-related indication in the context of Palliative Care, Psyence Biomedical Ltd is patient-centered, evidence-based, and physician-led by CEO Dr. Neil Maresky: News from Benzinga's psychedelic sector reporter Lara Goldstein on Psyence Biomedical Ltd's arrival on Nasdaq + Clinical Trials.
-
Integrative Oncology on the agenda when the Society for Integrative Oncology convenes on March 19 with GWI Wellness for Cancer Initiative and its founder, visionary julie bach Registration in link below. See everyone there. #PalliativeCare cc Global Wellness Institute Psychedelics & Healing Initiative
Wellness for Cancer 501c(3), Philanthropist, Anti-cancer lifestylist pioneer, GWI, SIO, NBHWC health coach, Yoga therapist
What an exciting gathering and discussion for cancer families, cancer care health workers and our GWI wellness community to unite around the important role of #Integrative Oncology and #Cancer Self-Help I have put together an amazing group from #Society of Integrative Oncology (SIO) and #The British Society of Integrative Oncology and #GWI Wellness for Cancer Initiative Let's Discuss what we heard, what #you heard, and share the real evidence, strategies and tactics we can all use. Please inbox me with any questions that you may want me to address Panelists include: Lanie Francis, MD Integrative Oncologist Hillman Cancer Center Aga Kehinde Cancer nurse and Co-chair of the British Society for Integrative Oncology Dr Rosy Daniel BSc MBBCh, Integrative Medicine Consultant, former IM Director Bristol Cancer Center (Now Penny Brohn) Jean Di Carlo-Wagner, M.A. Chair SIO Patient Advocate Special Interest Group Moderated by Julie Bach, Integrative Cancer Health Coach, Health Coach Chair SIO, SIO Patient Advocate SIG, and GWI Wellness for Cancer Initiative Chair #Register to join live or to receive a link to watch the recording at your convenience. https://lnkd.in/gzCzb6yp #SIO #Patient Advocate #Society Integrative Oncology #BSIO #nbhwc
-
-
Psyence Biomedical Ltd reposted this
Welcome to Dr. Albert Garcia-Romeu, PhD, Associate Professor, Johns Hopkins Center for Psychedelic and Consciousness Research who joins Psyence Biomedical Ltd as chair of its Scientific Advisory Board.
-
Celebrating our one year anniversary as the first life science biopharma developing nature-derived (non-synthetic) psilocybin-based medicine to list on the Nasdaq. Also celebrating the arrival of Johns Hopkins Center for Psychedelic and Consciousness Research professor Albert Garcia-Romeu, PhD to head the Psyence Biomedical Ltd Scientific Advisory Board, the commencement of our phase llb clinical trial, a debt-free balance sheet, and progress in our mission to alleviate human suffering and improve Palliative Medicine patient care through safe and effective FDA-approved, nature-derived, psilocybin-based psychedelic medicines.
This story is about a laughable idea 2 years ago... A story about perseverance, discipline, resolve A story about team work, collaboration, trust A story about rallying around a common vision, underpinning our company, to address the issues facing society of the Global Mental Health crisis, and improving the quality of life of patients suffering from incurable cancer. The rain couldn't stop our parade - Psyence Biomedical Ltd is a NASDAQ listed company 🌟 !!! #palliativecare #nasdaq #timessquare Ellenoff Grossman & Schole LLP Maxim Group LLC LifeSci Advisors, LLC Jody Aufrichtig Mary-Elizabeth Gifford Warwick Corden-Lloyd @Chris bull Marc Balkin Cohen & Company Capital Markets Taryn Lee Vos
-
-
Remarkable #psychedelic research on the agenda at SXSW when Albert Garcia-Romeu, PhD of the Johns Hopkins Center for Psychedelic and Consciousness Research and Psyence Biomedical Ltd's Scientific Advisory Board presents with his colleagues from Imperial College London, UC San Diego, and the Psychedelics and Pain Association
Associate Director of the Johns Hopkins Center for Psychedelic and Consciousness Research
Excited to head down to Austin for SXSW with colleagues from the University of California San Diego and the Psychedelics & Pain Association for our joint session titled, "Beyond the Mind: Psychedelics to Heal the Body." I'll present preliminary findings from a recently completed pilot study of psilocybin for post-treatment Lyme Disease.
-
Welcome to Albert Garcia-Romeu, PhD, researcher, scientist, professor. Albert P. Garcia-Romeu, Ph.D., to chair and develop Psyence Biomedical Ltd's newly created Scientific Advisory Board (SAB). Dr. Garcia-Romeu is a leading psychedelics researcher currently serving as Associate Director, Johns Hopkins Center for Psychedelic and Consciousness Research where he is the Susan Hill Ward Professor in Psychedelics and Consciousness. A highly sought after speaker on the therapeutic potential of psilocybin, with a particular emphasis on substance use disorder, Dr. Albert Garcia-Romeu, PhD has also served as co-investigator and co-primary investigator for numerous psilocybin clinical trials. https://lnkd.in/ewFte89x